Skip to main content
. Author manuscript; available in PMC: 2018 Feb 8.
Published in final edited form as: Vaccine. 2015 Mar 13;33(18):2152–2158. doi: 10.1016/j.vaccine.2015.03.009

Table 2.

Clinical symptoms observed in VLP-immune ferrets challenged with H7N9 virus.

Vaccine groupa Clinical symptoms of H7N9 challenged ferrets

Mean temp increase over baseline (3C)b Mean % weight lossc Mean peak viral titerd
VLP 2.0 7.4 5.0 ± 0.18
VLP + ISCOMATRIX 1.3 3.5 4.2 ± 0.04
PBS 2.3 12.7 6.5 ± 0.11
a

Ferrets were vaccinated i.m. two times with the 15 μg of H7N9 VLP.

b

Temperature increases over ferret baseline of 38.5 ± 0.2 °C, all maximum temperatures from day 2 p.c.

c

Mean maximum weight loss percentage values shown (day 7 or 8 post-challenge) for 6 ferrets per group.

d

Virus detected in nasal wash samples, mean peak titer shown as log10 pfu/ml including standard deviation. All peak titers from day 2 p.c.